Ophthalmology

Top Story

FDA accepts Roclatan new drug application

July 23, 2018
Meeting News

HAWK/HARRIER phase 3 results show non-inferiority of brolucizumab for BCVA gains in neovascular AMD

July 23, 2018
VANCOUVER, British Columbia — Brolucizumab achieved its primary endpoint of best corrected visual acuity noninferiority at week 48 to aflibercept in the results of…
Meeting NewsVideo

VIDEO: Real-world data show efficacy of Iluvien for DME

July 23, 2018
VANCOUVER, British Columbia At OIS Retina here, Dan Myers, CEO of Alimera Sciences, discusses the studies being presented at the American Society of Retina Specialists…
Meeting News

Treat-and-extend with ranibizumab comparable to monthly treatment for wet AMD

July 22, 2018
VANCOUVER, British Columbia — A 24-month treat-and-extend analysis trial with ranibizumab for patients with neovascular age-related macular degeneration showed…
Meeting News

Hundreds of clinics in US offering stem cell therapies without FDA approval

July 22, 2018
VANCOUVER, British Columbia — A cross-sectional, clinical study of stem cell therapy clinics found 40 companies with 76 clinics across the United States offering…
More Headlines »
Case Report

Bilateral Macular Choroidal Infarction as a Manifestation of Giant Cell Arteritis

Ophthalmic Surgery, Lasers and Imaging Retina, July 2018, Volume 49 Issue 7
The authors present an unusual case of bilateral macular choroidal infarction as a manifestation of giant cell…
More »
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because…
More »
Resource Centers
Video
Meeting News

VIDEO: Aerie continues push in glaucoma, retina products

July 3, 2018
More »